Literature DB >> 19735867

Combination treatment of hydrogen peroxide and X-rays induces apoptosis in human prostate cancer PC-3 cells.

Shinji Kariya1, Ken Sawada, Toshihiro Kobayashi, Takashi Karashima, Taro Shuin, Akihito Nishioka, Yasuhiro Ogawa.   

Abstract

PURPOSE: To study the effect of hydrogen peroxide (H(2)O(2)) on radiation-induced apoptosis in human prostate cancer PC-3 cells. METHODS AND MATERIALS: At 4h before the irradiation, PC-3 cells were exposed to 10mM ammonium chloride (NH(4)Cl) concentrations. Subsequently, cells were exposed to 0.1mM H(2)O(2) just before the irradiations, which were administered with 10-MV X-rays at doses of 10 Gy.
RESULTS: The percentage of apoptotic cells at 48 h after X-irradiation alone, H(2)O(2) alone, and combined X-irradiation and H(2)O(2) was 1.85%, 4.85%, and 28.4%, respectively. With use of combined X-irradiation and H(2)O(2), production of reactive oxygen species (ROS) occurred 4h after the irradiation. This resulted in lysosomal rupturing, mitochondrial fragmentation, and the release of cytochrome c into the cytoplasm from the mitochondria. In contrast, when cells were exposed to NH(4)Cl before the X-irradiation and H(2)O(2) administration, apoptosis was almost completely suppressed, ROS production did not occur, lysosomal rupture and mitochondrial fragmentation were blocked, and cytochrome c was not released.
CONCLUSIONS: Hydrogen peroxide strongly enhanced lysosome-dependent radiation-induced apoptosis in human prostate cancer PC-3 cells. A combined use of X-rays and H(2)O(2) can also injure the mitochondrial cytoplasmic organelles and lead to the production of ROS that in and of itself might possibly induce apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19735867     DOI: 10.1016/j.ijrobp.2009.04.092

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Development of a novel enzyme-targeting radiosensitizer (KORTUC) containing hydrogen peroxide for intratumoral injection for patients with low linear energy transfer-radioresistant neoplasms.

Authors:  Shiho Tokuhiro; Yasuhiro Ogawa; Kazuhiro Tsuzuki; Ryo Akima; Hironobu Ue; Shinji Kariya; Akihito Nishioka
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

2.  Management of non-vestibular schwannomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section. Part I: oculomotor and other rare non-vestibular schwannomas (I, II, III, IV, VI).

Authors:  Jarnail Bal; Michael Bruneau; Moncef Berhouma; Jan F Cornelius; Luigi M Cavallo; Roy T Daniel; Sebastien Froelich; Emmanuel Jouanneau; Torstein R Meling; Mahmoud Messerer; Pierre-Hugues Roche; Henry W S Schroeder; Marcos Tatagiba; Idoya Zazpe; Dimitrios Paraskevopoulos
Journal:  Acta Neurochir (Wien)       Date:  2021-11-09       Impact factor: 2.216

3.  Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer.

Authors:  Akihito Nishioka; Yasuhiro Ogawa; Kana Miyatake; Michiko Tadokoro; Munenobu Nogami; Norihiko Hamada; Kei Kubota; Shinnji Kariya; Takuhiro Kohsaki; Toshiji Saibara; Takehiro Okabayashi; Kazuhiro Hanazaki
Journal:  Oncol Lett       Date:  2014-04-28       Impact factor: 2.967

Review 4.  Paradigm Shift in Radiation Biology/Radiation Oncology-Exploitation of the "H₂O₂ Effect" for Radiotherapy Using Low-LET (Linear Energy Transfer) Radiation such as X-rays and High-Energy Electrons.

Authors:  Yasuhiro Ogawa
Journal:  Cancers (Basel)       Date:  2016-02-25       Impact factor: 6.639

5.  Development of a Novel Enzyme-Targeting Radiosensitizer (New KORTUC) Using a Gelatin-Based Hydrogel Instead of a Sodium Hyaluronate.

Authors:  Shiho Morita-Tokuhiro; Yasuhiro Ogawa; Norikazu Yokota; Akira Tsuzuki; Hideki Oda; Naoya Ishida; Nobutaka Aoyama; Akihito Nishioka
Journal:  Cancers (Basel)       Date:  2016-01-07       Impact factor: 6.639

6.  Lipid peroxidation increases hydrogen peroxide permeability leading to cell death in cancer cell lines that lack mtDNA.

Authors:  Kazuo Tomita; Yuko Takashi; Yuya Ouchi; Yoshikazu Kuwahara; Kento Igarashi; Taisuke Nagasawa; Hideki Nabika; Akihiro Kurimasa; Manabu Fukumoto; Yoshihiro Nishitani; Tomoaki Sato
Journal:  Cancer Sci       Date:  2019-07-27       Impact factor: 6.716

7.  Evaluation of Changes in Tumor Shadows and Microcalcifications on Mammography Following KORTUC II, a New Radiosensitization Treatment without any Surgical Procedure for Elderly Patients with Stage I and II Breast Cancer.

Authors:  Akira Tsuzuki; Yasuhiro Ogawa; Kei Kubota; Shiho Tokuhiro; Ryo Akima; Shin Yaogawa; Kenji Itoh; Yoko Yamada; Toshikazu Sasaki; Masahide Onogawa; Tomoaki Yamanishi; Shinji Kariya; Munenobu Nogami; Akihito Nishioka; Mitsuhiko Miyamura
Journal:  Cancers (Basel)       Date:  2011-09-09       Impact factor: 6.639

Review 8.  Mitochondrial stress signaling promotes cellular adaptations.

Authors:  Jayne Alexandra Barbour; Nigel Turner
Journal:  Int J Cell Biol       Date:  2014-01-22

9.  Computed Tomography Demonstration of the Production and Distribution of Oxygen Gas Following Intratumoral Injection of a New Radiosensitizer (KORTUC) for Patients with Breast Cancer-Is Intratumoral Injection Not an Ideal Approach to Solve the Major Problem of Tumor Hypoxia in Radiotherapy?

Authors:  Naoya Hayashi; Yasuhiro Ogawa; Kei Kubota; Kazuhiro Okino; Ryo Akima; Shiho Morita-Tokuhiro; Akira Tsuzuki; Shin Yaogawa; Akihito Nishioka; Mitsuhiko Miyamura
Journal:  Cancers (Basel)       Date:  2016-04-01       Impact factor: 6.639

10.  Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer.

Authors:  Yasuhiro Ogawa; Kei Kubota; Nobutaka Aoyama; Tomoaki Yamanishi; Shinji Kariya; Norihiko Hamada; Munenobu Nogami; Akihito Nishioka; Masahide Onogawa; Mitsuhiko Miyamura
Journal:  Cancers (Basel)       Date:  2015-11-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.